Solid Science.
Clinical Supply You Can Trust.
At Corealis Pharma, we combine deep formulation expertise, agile clinical manufacturing, and integrated infrastructure to help biotech innovators move from molecule to clinic, faster and with greater confidence.
We specialize in oral solid dosage (OSD) development, solving complex formulation challenges and translating them into robust, scalable drug products ready for clinical evaluation. From early-stage characterization to GMP manufacturing, every step is guided by science, built for execution, and aligned with the realities of biotech timelines.
Driven by flexibility, speed, and scientific rigor, we don’t just deliver results, we become a true extension of your team, adapting alongside your program to accelerate progress and reduce development risk.
Scientific Rigor
Transparent, Fast & Flexible
Collaboration & Trust
Facilities Built for Execution
Founded in 2005, Corealis Pharma has become an established, specialized oral solid dose CDMO with a focus on precision, agility, and scientific excellence.
Operating from its Laval headquarters, Corealis offers over 60,000 square feet of integrated R&D and GMP manufacturing space, enabling seamless progression from formulation through to clinical supply.
Today, Corealis supports partners with biotech companies advancing complex therapies across North America and Europe, delivering high-quality OSD solutions with speed, flexibility, and confidence.
Our Leadership Team
Driven by Experience. Focused on Results.
David Leroux-Petersen
Chief Executive Officer
Patrick Gosselin, Ph.D.
Vice-President, Pharmaceutical R&D
Yves Mouget, Ph.D.
Vice-President, Analytics
Pascal Tougas, CPA
Chief Financial Officer
Explore exciting career opportunities at Corealis and become a part of our innovative team
60,000+ sq ft
20+
27
900+
Our Difference
What sets Corealis apart is not just what we do, but how we do it.
Accelerated timelines supported by structured, science-driven processes.
Deep expertise in oral solid dosage forms, including complex and poorly soluble molecules.
Flexible, responsive teams aligned with biotech realities.
Extended capabilities through partnerships supporting later-stage and commercial pathways.
Visit Our Facility
Corealis Pharma’s facilities are purpose-built to support the full continuum of oral solid dose development, from early formulation through GMP clinical manufacturing.
We welcome clients to visit and engage directly with our scientific and technical teams. Experiencing the facility firsthand provides valuable insight into our processes, infrastructure, and quality systems, ensuring full confidence in how your program will be executed.
Complete Transparency / Full Visibility
Direct Access to Scientific Expertise
